Nova Patents
AT326484T

Monoclonal antibody against FLT4 RECEPTOR TYROSINE KINASE AND ITS USE IN DIAGNOSIS AND THERAPY

Abstract

ANTI-FLT4, ESPECIALLY anti FLT4 monoclonal antibodies, which are useful as a specific marker for endothelial cell of lymph vessels and HEV, AS A diagnostic tool to detect changes in lymphatic tissue, ESPECIALLY IN lymphatics and HEV IN THE UNITED SICK SUCH AS lymphangioma, MODULOS NODES AND INFLAMMATORY metastatic disease, infectious and immunological.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

153 members in 17 offices

This recordMember, by publication datePriority claim7 more offices are in the list below

Priority claims1

Priority claims
DocumentOfficeKindDate
25775494United States of AmericaA

Members153

Family members, oldest first
DocumentOfficeKind
CA2192235A1CanadaA1
WO9533772A1World Intellectual Property Organization (WIPO)A1
AU2738895AAustraliaA
NO965231D0NorwayD0
NO965231LNorwayL
FI964862AFinlandA
CA2228248A1CanadaA1
WO9705250A2World Intellectual Property Organization (WIPO)A2
AU6616996AAustraliaA
WO9705250A3World Intellectual Property Organization (WIPO)A3
EP0807124A1European Patent Office (EPO)A1
JPH10500858AJapanA
MX9606218AMexicoA
EP0842273A2European Patent Office (EPO)A2
US5776755AUnited States of AmericaA
AU694524B2AustraliaB2
CA2279554A1CanadaA1
WO9833917A1World Intellectual Property Organization (WIPO)A1
AU6262498AAustraliaA
NZ288235ANew ZealandA
WO9833917A9World Intellectual Property Organization (WIPO)A9
JPH11510689AJapanA
HK1014984A1Hong Kong, ChinaA1
AU711578B2AustraliaB2
EP0972028A1European Patent Office (EPO)A1
CA2345276A1CanadaA1
WO0021560A1World Intellectual Property Organization (WIPO)A1
AU1312100AAustraliaA
US6107046AUnited States of AmericaA
WO0021560A9World Intellectual Property Organization (WIPO)A9
US6130071AUnited States of AmericaA
NO20011759D0NorwayD0
US6221839B1United States of AmericaB1
NO20011759LNorwayL
US6245530B1United States of AmericaB1
NZ313647ANew ZealandA
EP1119371A1European Patent Office (EPO)A1
JP2001523951AJapanA
CN1329504AChinaA
US6361946B1United States of AmericaB1
AU748369B2AustraliaB2
US6403088B1United States of AmericaB1
CA2435503A1CanadaA1
WO02060950A2World Intellectual Property Organization (WIPO)A2
JP2002527404AJapanA
WO02060950A3World Intellectual Property Organization (WIPO)A3
AU748369CAustraliaC
US2003091567A1United States of AmericaA1
NO20033285D0NorwayD0
NO20033285LNorwayL
EP1353952A2European Patent Office (EPO)A2
US6645933B1United States of AmericaB1
WO02060950B1World Intellectual Property Organization (WIPO)B1
US2004037820A1United States of AmericaA1
NZ511408ANew ZealandA
US6730658B1United States of AmericaB1
CN1494552AChinaA
AU774266B2AustraliaB2
US2004147448A1United States of AmericaA1
US2004147726A1United States of AmericaA1
AU2004208675A1AustraliaA1
JP2004532004AJapanA
US2004208879A1United States of AmericaA1
US6818220B1United States of AmericaB1
US6824777B1United States of AmericaB1
EP0842273B1European Patent Office (EPO)B1
AT290594TAustriaT
ATE290594T1AustriaT1
DE69634437D1GermanyD1
JP2005139199AJapanA
DK0842273T3DenmarkT3
NO319383B1NorwayB1
NZ529063ANew ZealandA
PT842273EPortugalE
ES2238694T3SpainT3
JP3723210B2JapanB2
EP1612268A1European Patent Office (EPO)A1
AU2004208675B2AustraliaB2
AU2002300880B2AustraliaB2
DE69634437T2GermanyT2
US7034105B2United States of AmericaB2
EP0807124B1European Patent Office (EPO)B1
AT326484TThis recordAustriaT
ATE326484T1AustriaT1
DE69534996D1GermanyD1
US2006177901A1United States of AmericaA1
DK0807124T3DenmarkT3
PT807124EPortugalE
US7125714B2United States of AmericaB2
AU2002300880C1AustraliaC1
ES2263152T3SpainT3
EP1353952B1European Patent Office (EPO)B1
DE69534996T2GermanyT2
AT359300TAustriaT
ATE359300T1AustriaT1
DE60219419D1GermanyD1
DE60219419T2GermanyT2
AU2002248372B2AustraliaB2
CN100340291CChinaC
AU2002248372B8AustraliaB8
Showing 100 of 153